PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Accepted for Presentations at Major Conferences, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    ACR is the premier Rheumatology meeting, so the fact we get to present the DMOAD results is validation of the DMOAD results, otherwise the poster would've been knocked back. It's surprisingly difficult to get a slot at ACR and these posters go through a detailed selection process. In addition, this is the meeting where the best Rheumatologists from all around the world converge, so we should get some good attention. The only other thing I would add is the ACR is a great opportunity to collaborate, so hopefully Ravi and Mukesh keep this in mind when they attend. How do I know all this? Because I attended the 2018 one in Chicago where nearly 20,000 people were in attendence.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.